进展性皮质神经元损伤与烟雾灌注患者颅内外搭桥手术
回顾性研究用PET和11C标记氟马西尼评估18例搭桥手术的动脉粥样硬化性ICA或MCA疾病患者、8例药物治疗的烟雾灌注患者及7例健康对照的苯二氮䓬受体分布,发现搭桥术后烟雾灌注患者皮质苯二氮䓬受体指数变化显著大于无烟雾灌注手术患者和药物治疗的烟雾灌注患者。
要点
- 搭桥术后烟雾灌注患者皮质苯二氮䓬受体指数变化(27.5±15.6)显著大于无烟雾灌注手术患者(-5.2±9.4)。
- 搭桥术后烟雾灌注患者受体指数变化也显著大于药物治疗的烟雾灌注患者(3.2±15.4)。
- 烟雾灌注患者搭桥术后无围手术期卒中者仍可能出现进展性皮质神经元损伤。
核心结论
- 搭桥术后无围手术期卒中的烟雾灌注患者可能出现进展性皮质神经元损伤,且可能大于无干预缺血事件的药物治疗烟雾灌注患者。
研究设计与样本
- 回顾性研究,纳入18例搭桥手术的动脉粥样硬化性ICA或MCA疾病患者(9例烟雾灌注、9例无烟雾灌注)、8例药物治疗的烟雾灌注患者和7例健康对照,用PET和11C标记氟马西尼两次评估苯二氮䓬受体分布。
关键影像表现/征象
- 在MCA分布区脑皮质内量化苯二氮䓬受体的异常减低。
- 比较三组间苯二氮䓬受体指数的变化。
诊断标准与关键数值
- 苯二氮䓬受体指数变化:搭桥烟雾灌注组27.5±15.6(随访7±5个月),搭桥无烟雾灌注组-5.2±9.4(随访6±4个月),药物烟雾灌注组3.2±15.4(随访16±6个月)。
- 搭桥烟雾灌注组 vs 搭桥无烟雾灌注组 P < .001;搭桥烟雾灌注组 vs 药物烟雾灌注组 P < .01。
临床应用与阅片要点
- 烟雾灌注患者搭桥术后即使无围手术期卒中,仍需关注皮质神经元损伤进展的可能。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND AND PURPOSE: Misery perfusion may cause selective neuronal damage in atherosclerotic ICA or MCA disease. Bypass surgery can improve misery perfusion and may prevent neuronal damage. On the other hand, surgery conveys a risk for neuronal damage. The purpose of this retrospective study was to determine whether progression of cortical neuronal damage in surgically treated patients with misery perfusion is larger than that in surgically treated patients without misery perfusion or medically treated patients with misery perfusion.
MATERIALS AND METHODS: We evaluated the distribution of benzodiazepine receptors twice by using PET and 11C-labeled flumazenil in 18 surgically treated patients with atherosclerotic ICA or MCA disease (9 with misery perfusion and 9 without) and no perioperative stroke before and after bypass surgery; in 8 medically treated patients with misery perfusion and no intervening ischemic event; and in 7 healthy controls. We quantified abnormal decreases in the benzodiazepine receptors of the cerebral cortex within the MCA distribution and compared changes in the benzodiazepine receptor index among the 3 groups.
RESULTS: The change in the benzodiazepine receptor index in surgically treated patients with misery perfusion (27.5 ± 15.6) during 7 ± 5 months was significantly larger than that in surgically treated patients without misery perfusion (-5.2 ± 9.4) during 6 ± 4 months (P < .001) and in medically treated patients with misery perfusion (3.2 ± 15.4) during 16 ± 6 months (P < .01).
CONCLUSIONS: Progression of cortical neuronal damage in surgically treated patients with misery perfusion and no perioperative stroke may occur and may be larger than that in medically treated patients with misery perfusion and no intervening ischemic event.
引用
- Yamauchi H, Kagawa S, Kishibe Y, et al. Progressive Cortical Neuronal Damage and Extracranial-Intracranial Bypass Surgery in Patients with Misery Perfusion. AJNR Am J Neuroradiol. 2017. PMID: 28255031. doi:10.3174/ajnr.A5110
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。